Home About Lux The Lux Team Client Portfolio News Contact Information

Lux Capital Management is a research-driven investment firm focused on de novo, seed and early stage investments in the physical and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Our investment team has built over 20 companies from scratch.
Portfolio - Lux Research
Portfolio - Lux Research
Portfolio - Nanosys
Portfolio - Magen
Portfolio - Cambrios
Portfolio - Tempo Pharmaceuticals
Portfolio - Genocea
Portfolio - Accelergy
Portfolio - Molecular Imprints
Portfolio - Kereos
Portfolio - Silicon Clocks
Genocea Wins "Best Vaccine Startup" at World Vaccine Congress
Sirtris Pharmaceuticals- co-founded by Lux Venture Partner David Sinclair - acquired by GlaxoSmithKline
Lux Research Names Dennis Philbin new CEO
Lux joins $8 million financing round for Silicon Clocks
Lux invests in $12 million Series A round for Tempo Pharmaceuticals